✨ Your Portfolio is fetched and updated from zerodha.
Micro Chemicals
Market Cap
₹559 Cr.
P/E
22.32
About
Kronox Lab Sciences is a bulk manufacturer of high purity fine chemicals meeting industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR, and ACS. They cater to pharmaceutical, nutraceutical, vet… Read more
Kronox Lab Sciences is a bulk manufacturer of high purity fine chemicals meeting industry stan… Read more
Low
134
52W Range
High
229
  • Kronox Lab Sciences
  • Naperol Investments
  • Stallion India Fluor

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

3 Neutral

Neutral for this company

2 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operational Metrics

    Select a Metric
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Kronox Lab Sciences Ltd. Business

    Kronox Lab Sciences is a bulk manufacturer of high purity fine chemicals, in compliance with Reagent, Pharmacopoeia and various Food Grade standards, for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets.Its products are manufactured in accordance with industry standards like IP, BP, EP, JP, USP, FCC, LR, AR, GR and ACS in addition to custom manufacturing specifications, which differ from the industry standards, required by its customers in select cases.

    Kronox Lab Sciences major competitors are Naperol Investments, Vikram Thermo(India), Stallion India Fluor, Sunshield Chemicals, HP Adhesives, Plastiblends India, Andhra Petrochem.
    Market Cap of Kronox Lab Sciences is ₹555 Crs.
    While the median market cap of its peers are ₹570 Crs.

    Kronox Lab Sciences seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    []
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material